MedPageToday -- Increasing the dose of an anti-tumor necrosis factor (TNF) drug in patients with rheumatoid arthritis is unlikely to increase the therapeutic response, an observational study found.
MedPageToday -- Increasing the dose of an anti-tumor necrosis factor (TNF) drug in patients with rheumatoid arthritis is unlikely to increase the therapeutic response, an observational study found.